Evidence library 26 analyses
A fisetin evidence hub covering senolytic research, human trials, bioavailability, dosing, safety and supplement quality.
Complete library
Browse every published guide, review and evidence update in this topic.
Fisetin has substantial preclinical neuroprotection research, including Alzheimer’s and cognitive-aging models. Human evidence remains minimal: a five-person mild-Alzheimer’s safety pilot completed in 2026 without posted results, while another...
Fisetin has one genuine mouse study behind it for hair growth, via a TERT-activation mechanism. Grey hair reversal claims are not supported by any fisetin research. Here is...
Fisetin has preclinical skin evidence from UVB, dermal-senescence and diabetic-wound models. A 2026 topical mouse study improved dermal/granulation balance and reduced fibrosis but did not significantly speed wound...
Fisetin is studied as a candidate senolytic, while apigenin is studied for CD38 inhibition and other flavonoid effects. Both have substantial preclinical biology but limited human evidence for...
Fisetin and resveratrol are longevity-focused polyphenols with different proposed mechanisms, poor oral exposure and mixed translational evidence. Fisetin shows senolytic activity in selected preclinical models; neither compound has...
Compare ten fisetin supplements on ingredient transparency, batch testing, formulation and dose format, with US/UK/Canada purchasing considerations. DoNotAge Pure Fisetin is our featured single-ingredient option and an affiliate...
Fisetin has broad preclinical anti-inflammatory activity, but human evidence is mixed. Small trials report selected biomarker changes, while the completed knee-osteoarthritis trial found no consistent benefit over placebo;...
A 2025 mouse study linked intermittent fisetin with better physical function and lower skeletal-muscle senescence markers in aged mice. Human studies are now testing frailty and physical-function questions,...
